PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TAXANE DERIVATIVES

Title:

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TAXANE DERIVATIVES

Document Type and Number:

WIPO Patent Application WO2004043390

Kind Code:

A3

Abstract:

The present invention relates to a novel intravenous formulation for a taxane chemotherapeutic agent. The agent is formulated as a two-container, i.e. vial system, with one container holding the therapeutic agent in a solvent with a buffer and the other container holding a co-solvent in a buffer. The contents of the two containers are mixed prior to administration.

More Like This:

WO/2018/039496	CO-CROSSLINKED HYALURONIC ACID-SILK FIBROIN HYDROGELS FOR IMPROVING TISSUE GRAFT VIABILITY AND FOR SOFT TISSUE AUGMENTATION
WO/2007/057717	PHARMACEUTICAL DEVICE FOR THE ADMINISTRATION OF SUBSTANCES TO PATIENTS
WO/2005/072759	EFFERVESCENT COMPOSITION INCLUDING CRANBERRY EXTRACT

Inventors:

GOGATE UDAY SHANKAR (US)

Application Number:

PCT/US2003/035833

Publication Date:

July 15, 2004

Filing Date:

November 07, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BRISTOL MYERS SQUIBB CO (US)
GOGATE UDAY SHANKAR (US)
PERRONE ROBERT KEVIN (US)
RAGHAVAN KRISHNASWAMY SRINIVAS (US)

International Classes:

A61K9/00; A61K31/337; A61K47/10; A61K47/12; A61K47/44; (IPC1-7): A61K31/337

Foreign References:

US6232477B1

2001-05-15

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS OF TREATING CANCER AND RELATED METHODS

Next Patent: MODULATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11 EXPRESSION